JP4361142B2 - 白血球の内因性ペルオキシダーゼ活性に基く、新鮮並びに時間を置いた全血試料についての白血球分画計数を実施するための改良された方法と試薬組成物 - Google Patents

白血球の内因性ペルオキシダーゼ活性に基く、新鮮並びに時間を置いた全血試料についての白血球分画計数を実施するための改良された方法と試薬組成物 Download PDF

Info

Publication number
JP4361142B2
JP4361142B2 JP14482696A JP14482696A JP4361142B2 JP 4361142 B2 JP4361142 B2 JP 4361142B2 JP 14482696 A JP14482696 A JP 14482696A JP 14482696 A JP14482696 A JP 14482696A JP 4361142 B2 JP4361142 B2 JP 4361142B2
Authority
JP
Japan
Prior art keywords
composition
reagent
surfactant
sample
white blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP14482696A
Other languages
English (en)
Japanese (ja)
Other versions
JPH08308593A (ja
Inventor
マイクル、ジェイ、メイリン
フィリス、シャピロ
ジァン、エフ、クレミンズ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Inc
Original Assignee
Siemens Healthcare Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Healthcare Diagnostics Inc filed Critical Siemens Healthcare Diagnostics Inc
Publication of JPH08308593A publication Critical patent/JPH08308593A/ja
Application granted granted Critical
Publication of JP4361142B2 publication Critical patent/JP4361142B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664—Blood serum or blood plasma standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Ecology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP14482696A 1995-05-16 1996-05-16 白血球の内因性ペルオキシダーゼ活性に基く、新鮮並びに時間を置いた全血試料についての白血球分画計数を実施するための改良された方法と試薬組成物 Expired - Lifetime JP4361142B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/442491 1995-05-16
US08/442,491 US5639630A (en) 1995-05-16 1995-05-16 Method and reagent composition for performing leukocyte differential counts on fresh and aged whole blood samples, based on intrinsic peroxidase activity of leukocytes

Publications (2)

Publication Number Publication Date
JPH08308593A JPH08308593A (ja) 1996-11-26
JP4361142B2 true JP4361142B2 (ja) 2009-11-11

Family

ID=23756987

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14482696A Expired - Lifetime JP4361142B2 (ja) 1995-05-16 1996-05-16 白血球の内因性ペルオキシダーゼ活性に基く、新鮮並びに時間を置いた全血試料についての白血球分画計数を実施するための改良された方法と試薬組成物

Country Status (12)

Country Link
US (1) US5639630A (fr)
EP (1) EP0743519B1 (fr)
JP (1) JP4361142B2 (fr)
KR (1) KR960042055A (fr)
AT (1) ATE223043T1 (fr)
AU (1) AU699086C (fr)
CA (1) CA2173519A1 (fr)
DE (1) DE69623174T2 (fr)
ES (1) ES2181821T3 (fr)
IL (1) IL117862A (fr)
PT (1) PT743519E (fr)
TW (1) TW448295B (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888752A (en) * 1995-05-16 1999-03-30 Bayer Corporation Universal rinse reagent and method for use in hematological analyses of whole blood samples
US5843608A (en) * 1995-06-08 1998-12-01 Coulter International Corp. Reagent and method for differential determination of leukocytes in blood
US5817518A (en) * 1995-12-18 1998-10-06 Coulter International Corp. Reagent and method for differential determination of leukocytes in blood
US5830701A (en) * 1997-03-28 1998-11-03 Tao Medical Electronics Co., Ltd. Method of detecting hematopoietic progenitor cells
JP3830613B2 (ja) * 1997-04-18 2006-10-04 シスメックス株式会社 血液中の白血球及びヘモグロビン濃度測定試薬
US5858794A (en) * 1997-05-13 1999-01-12 Bayer Corporation Cyanide-containing hemoglobin reagent composition and method providing acceptable precision, accuracy and freedom from white cell interference on automated hematology analyzers
US8071384B2 (en) * 1997-12-22 2011-12-06 Roche Diagnostics Operations, Inc. Control and calibration solutions and methods for their use
US7494816B2 (en) 1997-12-22 2009-02-24 Roche Diagnostic Operations, Inc. System and method for determining a temperature during analyte measurement
AU740441B2 (en) * 1998-06-30 2001-11-01 La Mina Ltd Cytological and histological fixative composition and methods of use
FR2782166B1 (fr) * 1998-08-04 2000-10-06 Abx Sa Reactif pour la mesure de l'hemoglobine et la determination des leucocytes dans un echantillon de sang
WO2000058726A1 (fr) 1999-03-29 2000-10-05 Asahi Kasei Kabushiki Kaisha Procede de numeration des leucocytes dans un echantillon de sang complet
US6225124B1 (en) * 1999-06-02 2001-05-01 Sysmex Corporation Diluting reagent and method compelling time-independent consistency in MCV assay
US6632676B1 (en) * 1999-09-24 2003-10-14 Clinical Diagnostic Solutions Multi-purpose reagent system and method for enumeration of red blood cells, white blood cells and thrombocytes and differential determination of white blood cells
CA2414626A1 (fr) 2000-07-04 2002-01-10 Bioimage A/S Technique permettant d'extraire des informations quantitatives relatives aux interactions entre des composants cellulaires
CA2447586A1 (fr) * 2002-11-01 2004-05-01 Streck Laboratories, Inc. Reactif et methodes ameliores pour hematologie
US7723099B2 (en) * 2003-09-10 2010-05-25 Abbott Point Of Care Inc. Immunoassay device with immuno-reference electrode
US7803523B2 (en) * 2004-08-27 2010-09-28 University Health Network Whole blood preparation for cytometric analysis of cell signaling pathways
CA2579001C (fr) * 2004-09-01 2014-07-08 Maine Standards Company, Llc Nouvelles normes de lipides stables
US7625757B2 (en) 2006-01-27 2009-12-01 Sysmex Corporation Reagent for immature leukocyte analysis and reagent kit
CN101078720B (zh) * 2006-05-22 2010-12-01 深圳迈瑞生物医疗电子股份有限公司 一种改进的用于对白细胞进行分类的试剂及方法
CN101078721B (zh) * 2006-05-23 2010-12-22 深圳迈瑞生物医疗电子股份有限公司 对白细胞进行分类的试剂及方法
ATE452336T1 (de) 2006-06-06 2010-01-15 Hoffmann La Roche Gebrauchsfertiges sammelgefäss für vollblut
US20080026366A1 (en) * 2006-06-07 2008-01-31 Newcomer Supply, Inc. Biological fixative and method of using the biological fixative
US7449337B2 (en) * 2007-01-24 2008-11-11 Idexx Laboratories, Inc. Lytic reagent and method for leukocytes differential in whole blood
CN101311725B (zh) * 2007-05-25 2014-03-26 深圳迈瑞生物医疗电子股份有限公司 一种五分类白细胞质控物及其制备方法
CN101349644B (zh) * 2007-07-20 2012-06-27 深圳迈瑞生物医疗电子股份有限公司 一种白细胞分类试剂和其使用方法
US8642664B2 (en) 2007-08-06 2014-02-04 Samir Mitragotri Composition for solubilizing tissue and cells comprising N-tetradecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate and polyoxyethylene (10) cetyl ether
US9814422B2 (en) 2007-08-06 2017-11-14 The Regents Of The University Of California Compositions for solubilizing cells and/or tissue
WO2009048681A2 (fr) 2007-08-06 2009-04-16 The Regents Of The University Of California Procédés de diagnostic à base de tissus
US8102161B2 (en) * 2007-09-25 2012-01-24 Tdk Corporation Stable output in a switching power supply by smoothing the output of the secondary coil
CN105440725A (zh) * 2008-01-04 2016-03-30 深圳迈瑞生物医疗电子股份有限公司 不对称菁类荧光染料，组合物及在生物样品染色中的用途
CN101602762B (zh) * 2008-06-10 2013-10-16 深圳迈瑞生物医疗电子股份有限公司 不对称菁类化合物、其制备方法及应用
CN101726579B (zh) * 2008-10-17 2014-06-18 深圳迈瑞生物医疗电子股份有限公司 血液检测试剂和方法
CN101750274B (zh) * 2008-12-17 2014-06-25 深圳迈瑞生物医疗电子股份有限公司 白细胞分类计数试剂、试剂盒以及白细胞分类计数的方法
ES2799891T3 (es) * 2009-02-13 2020-12-22 Univ California Dispositivo, composición y método para el diagnóstico basado en tejidos
CN101988082B (zh) * 2009-07-31 2015-04-08 深圳迈瑞生物医疗电子股份有限公司 白细胞分类计数试剂、试剂盒及其制备方法和白细胞分类计数的方法
US9091677B2 (en) 2010-08-09 2015-07-28 Beckman Coulter, Inc. Isotonic buffered composition and method that enables counting of cells
WO2013147309A1 (fr) * 2012-03-30 2013-10-03 積水メディカル株式会社 Procédé de mesure d'une substance dans un échantillon de sang
MX369625B (es) * 2012-05-16 2019-11-14 Univ California Composiciones para solubilizar celulas y/o tejido.
CN104981692B (zh) * 2013-03-12 2019-09-20 雅培实验室 用于分析白细胞的试剂、体系及方法
BE1021926B1 (nl) * 2014-04-01 2016-01-27 FertiPro N.V. Werkijze voor semenanalyse
WO2019111355A1 (fr) * 2017-12-06 2019-06-13 オリンパス株式会社 Méthode de création de modèle d'apprentissage, méthode de traitement d'image, dispositif de création de modèle d'apprentissage, dispositif de traitement d'image, programme de création de modèle d'apprentissage et programme de traitement d'image
JP7143678B2 (ja) * 2018-08-24 2022-09-29 東ソー株式会社 標的細胞を検出する方法
WO2020042027A1 (fr) * 2018-08-29 2020-03-05 深圳迈瑞生物医疗电子股份有限公司 Méthode d'essai d'échantillon de sang, dispositif d'essai d'échantillon de sang et support d'informations
WO2020252692A1 (fr) * 2019-06-19 2020-12-24 深圳迈瑞生物医疗电子股份有限公司 Analyseur de cellules, procédé de classification de globules blancs basé sur un procédé d'impédance et support d'enregistrement lisible par ordinateur
CN111239120A (zh) * 2020-02-26 2020-06-05 绍兴市人民医院 一种血液钙离子检测试纸
US12498371B2 (en) 2021-12-23 2025-12-16 Hi Technologies Ltda Formulation for total and differential counting of leukocytes in liquid medium and method of making and using same
WO2025202842A1 (fr) * 2024-03-26 2025-10-02 Asima Health Inc. Procédé de stadification du cancer utilisant la spectroscopie d'impédance

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3741875A (en) * 1970-10-30 1973-06-26 Mount Sinai Res Foundation Inc Process and apparatus for obtaining a differential white blood cell count
US4099917A (en) * 1977-07-21 1978-07-11 Technicon Instruments Corporation Process for preparing a cell suspension from blood for discrimination of white blood cells and platelets from other blood particles
US4506018A (en) * 1982-12-30 1985-03-19 Becton, Dickinson And Company Blood diluent
CA1255197A (fr) * 1984-09-24 1989-06-06 Joseph L. Orlik Compose et methode pour la differenciation des leucocytes
AU602129B2 (en) * 1985-09-06 1990-10-04 Technicon Instruments Corportion Method for the determination of a differential white blood cell count
US4978624A (en) * 1985-09-06 1990-12-18 Technicon Instruments Corporation Reagent for the determination of a differential white blood cell count
US4801549A (en) * 1985-09-06 1989-01-31 Technicon Instruments Corporation Method for the determination of a differential white blood cell count
US5426029A (en) * 1986-03-31 1995-06-20 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using leukocyte surface antigens
US5262302A (en) * 1987-03-13 1993-11-16 Coulter Corporation Method for screening white blood cells
US5389549A (en) * 1987-05-29 1995-02-14 Toa Medical Electronics Co., Ltd. Method for classifying leukocytes and a reagent used therefor
WO1988009504A1 (fr) * 1987-05-29 1988-12-01 Toa Medical Electronics Co., Ltd. Procede de classification de leucocytes et reactifs utilises
JP2619900B2 (ja) * 1988-01-27 1997-06-11 東亜医用電子株式会社 血液中の白血球およびヘモグロビンの測定用試薬および方法
CA2016699C (fr) * 1989-05-15 2003-11-18 Paul N. Marshall Agents lytiques et leurs usages
US5116734A (en) * 1989-09-01 1992-05-26 Digene Diagnostics, Inc. Highly sensitive method for detecting peroxidase
IT8921788A0 (it) * 1989-09-21 1989-09-21 Diesse Diagnostica Reattivo utile per la rilevazione e la determinazione quantitativa dei leucociti in fluidi biologici.
FR2654744B1 (fr) * 1989-11-20 1992-03-13 Abx Sa Reactif et methode d'utilisation de celui-ci pour la determination automatique en cytometrie de flux d'au moins une sous-population leucocytaire a partir du sang total.
US5227304A (en) * 1991-01-16 1993-07-13 Sequoia Turner Corporation Method for counting whole blood diluent and detergent reagent system
JP3048260B2 (ja) * 1991-07-29 2000-06-05 シスメックス株式会社 白血球分類計数用試料調製方法
US5525461A (en) * 1991-11-01 1996-06-11 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using total leukocyte surface antigens
JP3467310B2 (ja) * 1994-04-21 2003-11-17 シスメックス株式会社 白血球分析用試薬及び白血球の分類方法

Also Published As

Publication number Publication date
CA2173519A1 (fr) 1996-11-17
AU699086C (en) 2001-06-21
EP0743519B1 (fr) 2002-08-28
DE69623174T2 (de) 2002-12-19
JPH08308593A (ja) 1996-11-26
EP0743519A2 (fr) 1996-11-20
AU5226296A (en) 1996-11-28
ATE223043T1 (de) 2002-09-15
US5639630A (en) 1997-06-17
DE69623174D1 (de) 2002-10-02
AU699086B2 (en) 1998-11-19
IL117862A0 (en) 1996-08-04
ES2181821T3 (es) 2003-03-01
TW448295B (en) 2001-08-01
EP0743519A3 (fr) 1998-07-29
KR960042055A (ko) 1996-12-19
PT743519E (pt) 2002-12-31
IL117862A (en) 1999-12-22

Similar Documents

Publication Publication Date Title
JP4361142B2 (ja) 白血球の内因性ペルオキシダーゼ活性に基く、新鮮並びに時間を置いた全血試料についての白血球分画計数を実施するための改良された方法と試薬組成物
KR100452013B1 (ko) 전혈샘플의혈액분석에사용하기위한만능린스시약조성물
EP0874988B1 (fr) Reactif et procede de differenciation des leucocytes du sang
US6509192B1 (en) Quality control method
US6573102B2 (en) Lytic reagent composition for determination of nucleated blood cells
US7135341B2 (en) Reference control containing a nucleated red blood cell component
US20040209377A1 (en) Lytic reagent composition for leukocyte differential analysis
US20060269970A1 (en) Method for a fully automated monoclonal antibody-based extended differential
JP2001524666A (ja) 赤芽球の識別方法
JP3822625B2 (ja) 血液学的コントロール製品
US8802025B2 (en) Reagent kit for sample analysis and sample analysis method
US5843608A (en) Reagent and method for differential determination of leukocytes in blood
US6362003B1 (en) Hematological reference control composition containing leukocyte analogs, methods of making, and uses thereof
CA2428740A1 (fr) Methode automatisee et reactif pour le dosage de liquides organiques tels que le liquide cephalorachidien (lcr)
US6472168B2 (en) Process for counting sperms and reagent therefor
KR101993965B1 (ko) 소변 시료 분석 방법, 소변 시료 분석용 시약 및 소변 시료 분석용 시약 키트
HU216303B (hu) Áramlásos citometriai reagens

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20030509

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070116

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20070329

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20070403

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070717

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080212

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20080404

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20080404

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080611

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20080723

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081023

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20080404

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20090224

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090324

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090623

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090714

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090812

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120821

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120821

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130821

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term